fbpx

U.S. Anti-Doping Agency (USADA)

Global DRO logo in whiteSearch Medications & Ingredients

U.S. Wheelchair Curling Athlete, Robert Prenoveau, Accepts Public Warning for Anti-Doping Rule Violation

March 7, 2017

USADA announced today that Robert Prenoveau, of Chittenango, N.Y., an athlete in the sport of wheelchair curling, has accepted a public warning for his anti-doping rule violation.

Prenoveau, 51, tested positive for the presence of hydrochlorothiazide and related metabolites as a result of an in-competition urine sample he provided on November 5, 2016, at the Wheelchair National Team Trials in Wausau, Wis. Hydrochlorothiazide is in the class of Diuretics and Masking Agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the World Curling Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency (WADA) Prohibited List.

After a thorough review of the case, including the examination of medical records provided by the athlete, USADA determined that Prenoveau’s positive test was caused by a prescribed medication that he was using in a therapeutic dose under the care of a physician. USADA has since granted Prenoveau a Therapeutic Use Exemption authorizing his continued use of this medication.

In addition to accepting a public warning, Prenoveau has been disqualified from all competitive results obtained on November 5, 2016, the date his positive sample was collected, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

Scroll to Top